Senseonics Holdings, Inc. engages in the design, development, and commercialization of glucose monitoring systems for people with diabetes. The company’s first generation continuous glucose monitoring (CGM) system, Eversense, is designed to measure glucose levels in people with diabetes for a period of up to 90 days. Its CGM system includes a miniaturized sensor that is designed to be implanted into the subcutaneous space of the upper arm to communicate with the transmitter; and to function noninvasively, automatically, and continuously for up to 90 days before replacement. Senseonics Holdings, Inc. was formerly known as Senseonics, Inc. and changed its name to Senseonics Holdings, Inc. in D...
20451 Seneca Meadows Parkway
Germantown, MD 20876
Founded in 1996
Senseonics Holdings, Inc. and Senseonics, Incorporated Enter into Second Amendment to Loan and Security Agreement
Feb 9 16
On February 4, 2016, Senseonics Holdings, Inc. and Senseonics, Incorporated, entered into a Second Amendment to Loan and Security Agreement with Oxford Finance, LLC, effective as of January 29, 2016. The Amendment, among other things, modifies the amortization schedule of that certain Loan and Security Agreement, by and among Senseonics Holdings, Subsidiary and Oxford, dated July 31, 2014, as amended. The secured notes previously issued pursuant to the Loan Agreement require monthly payments. Pursuant to the Amendment, if Senseonics Holdings receives a CE mark for its continuous glucose monitoring system, Eversense, by March 4, 2016 or Senseonics Holdings receives net cash proceeds of at least $2,500,000 from the sale of equity securities or a convertible note to Energy Capital, LLC by March 4, 2016 and receives a CE mark for Eversense by March 31, 2016 and, each, a ‘CE Mark Approval Event’, the monthly payments will convert to payments of principal and interest, beginning on August 1, 2016, with the principal amount being amortized over the ensuing 36 months. If a CE Mark Approval Event does not occur, the monthly payments will convert to payments of principal and interest beginning on April 1, 2016, with the principal amount being amortized over the ensuing 40 months. In addition, the Amendment extends the amount of time Senseonics Holdings has to borrow up to an additional $5.0 million under the Loan Agreement on the same terms and conditions of the existing Notes. Pursuant to the Amendment, Senseonics Holdings can borrow the additional $5.0 million following a CE Mark Approval Event until the earliest of March 4, 2016, if an Equity Event does not occur by March 4, 2016, March 31, 2016, if an Equity Event occurs by March 4, 2016, 30 days after the Draw Period commences and the occurrence of an Event of Default. Except as modified by the Amendment, all terms and conditions of the Loan Agreement remain in full force and effect.
Senseonics Holdings, Inc. Signs a Collaboration Agreement with Diasend
Feb 2 16
Senseonics Holdings, Inc. announced that it has signed a collaboration agreement with Diasend that will allow clinical review of patients CGM data from the Eversense® Continuous Glucose Monitoring (CGM) System using the diasend® Clinic and diasend® Personal solutions. Under this agreement, the two companies will work together to enable clinicians and patients to utilize the diasend® solution to review past Eversense CGM data along with insulin pump and activity tracker data. Senseonics is developing Eversense as a reliable, long-term implantable CGM system to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 days, while the diasend solutions allow users to review glucose reports in familiar and unified formats. The companies are collaborating to integrate Eversense CGM system with the diasend® solutions, thereby allowing clinicians and patients to access 90 days of continuous glucose data from a single CGM sensor to aid in optimizing therapy regimens.
ASN Technologies, Inc. will Change its Name to Senseonics Holdings, Inc
Dec 21 15
Effective December 22, 2015, ASN Technologies, Inc. will change its name to Senseonics Holdings, Inc.